CSF APPsα and Phosphorylated Tau Protein Levels in Mild Cognitive Impairment and Dementia of Alzheimer's Type

Journal of Geriatric Psychiatry and Neurology - Tập 22 Số 1 - Trang 3-9 - 2009
Andreas Fellgiebel1, Elżbieta Kojro2, Matthias J. Müller3, Armin Scheurich3, Lutz Schmidt3, Falk Fahrenholz2
1Department of Psychiatry, Johannes Gutenberg University Mainz, Germany, -mainz.de
2Institute of Biochemistry, Johannes Gutenberg University, Mainz, Germany
3Department of Psychiatry, Johannes Gutenberg University, Mainz, Germany

Tóm tắt

We exploratively measured APPsα, a secreted fragment of the non-amyloidogenic cleavage of amyloid precursor protein via a-secretase, and tau protein phosphorylated at threonine 181 (ptau) in the cerebrospinal fluid of 10 patients with mild cognitive impairment, 20 patients with dementia of Alzheimer's type, and 10 controls. Cerebrospinal fluid APPsα and ptau levels were correlated with cognitive performance. Ptau levels were significantly elevated in mild cognitive impairment and in patients with dementia of Alzheimer's type, APPsα levels were significantly reduced in patients with dementia of Alzheimer's type compared to the controls. APPsα levels were associated with Mini Mental State Examination total scores but not with Delayed Verbal Recall Test performance. Vice versa, ptau levels correlated only with Delayed Verbal Recall Test in patients with dementia of Alzheimer's type or mild cognitive impairment. Both, an increase in ptau levels and a decrease in cerebrospinal fluid APPsα, seem to refer to relevant but functionally different processes in the development of mild cognitive impairment and dementia of Alzheimer's type.

Từ khóa


Tài liệu tham khảo

10.1126/science.1079469

10.1126/science.1062097

10.1016/j.neuron.2004.07.003

10.1152/physrev.2001.81.2.741

10.1016/S0006-291X(02)02635-9

10.1007/s004010100423

10.1016/S0361-9230(03)00087-X

10.1007/s00702-003-0065-z

10.1016/S1474-4422(06)70355-6

10.1038/nm0895-829

10.1016/S0304-3940(99)00929-5

10.1001/archneur.1997.00550170111022

10.1016/S0306-4522(99)00244-4

10.1212/WNL.43.11.2412-a

10.1001/archneur.56.3.303

10.1001/archpsyc.61.1.95

10.1034/j.1600-0404.107.s179.9.x

10.1212/01.wnl.0000183284.92920.f2

10.1016/j.neurobiolaging.2005.07.003

10.1016/j.biopsych.2004.05.014

10.1373/clinchem.2004.039347

10.1016/S0304-3940(02)01481-7

10.1001/archneur.58.12.1985

10.1212/WNL.44.4.609

10.1007/BF02815140

10.1016/S0304-3940(00)01036-3

10.1111/j.1532-5415.1992.tb01992.x

10.1016/S0028-3932(99)00111-6

10.1001/archneur.1995.00540350081020

10.1001/archneur.1991.00530150046016

10.1001/archneur.63.5.665

10.1016/j.neurobiolaging.2003.09.009

10.1016/j.nbd.2005.03.005

10.1073/pnas.0403921101

10.1172/JCI20864

10.1159/000069989

Thông tin
Thông tin xuất bản

Journal of Geriatric Psychiatry and Neurology

Tập 22 Số 1

3-9

Thông tin tác giả